Overall, the above studies indicate that FAK contributes to the progression of breast cancer via the promotion of adhesion and migration while contributing to the progression of prostate cancer via the promotion of proliferation, invasion, migration, and metastasis. The gene discussed is PTK2; the disease is Familial prostate cancer.